CE mark of approval for cataract laser system


The CE mark of approval has been given to OptiMedica's Catalys Precision Laser System.

The CE mark of approval has been given to OptiMedica's Catalys Precision Laser System.

The Catalys has been approved to deliver capsulotomy and lens fragmentation. OptiMedica are currently awaiting approval for corneal incisions - anticipated in the near future.

The laser system incorporates the use of a femtosecond laser and optical coherence tomography (OCT) imaging. The optical path to the patient's eye is optimized to guarantee stable system-patient attachment due to the Liquid Optics Interface. Catalys also offers a proprietary Integral Guidance system that ensures safe and precise femtosecond laser pulses during surgery. The graphical user interface is simple to use and reduces patient time under the dock.

Dr William Culbertson, Professor of Ophthalmology, Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, USA, said, "The system's CE mark of approval is a tremendous milestone that rewards years of intense collaboration to deliver the greatest precision and best experience for both surgeon and patient."

Mark J. Forchette, OptiMedica's president and chief executive officer, added, "We are excited to enter this new stage in OptiMedica's history, and we look forward to introducing Catalys to markets around the world in the very near future."

The first shipment of the Catalys will be introduced to Europe late this year.

If you would like to read more on this system please click here for an article by Dr Jonathan Talamo that was published in April's print issue of OTEurope on his experiences with the system and his thoughts on femtosecond laser cataract surgery.

Related Videos
Josefina Botta, MD, MSc, at ASCRS 2024
Dr Nir Shoham Hazon, Director, Miramichi EyeNB Centre of Excellence, New Brunswick, Canada
J. Morgan Micheletti, MD, speaks at the 2024 ASCRS meeting
Dr William Wiley of Cleveland Eye Clinic, Northeast Ohio
© 2024 MJH Life Sciences

All rights reserved.